Description

Turinabol 10 mg by Swiss Healthcare contains Chlorodehydromethyltestosterone, an oral anabolic-androgenic steroid (AAS) historically used in clinical and athletic research for its ability to support lean muscle mass, strength, and recovery without significant water retention or estrogenic side effects.

Often referred to as “Tbol,” Turinabol is structurally similar to Dianabol but with reduced androgenic activity and no aromatization to estrogen, making it a preferred compound in research focused on clean, steady anabolic responses. Its mild profile and oral format make it suitable for controlled laboratory studies involving anabolic pathways, muscle preservation, and nitrogen retention.

Manufactured to pharmaceutical-grade standards, Turinabol 10 mg is supplied in bottles containing 60 oral tablets, offering precise dosing and ease of use for research-only environments.

Product Details

• Active Ingredient: Chlorodehydromethyltestosterone (Turinabol)

• Concentration per Tablet: 10 mg

• Form: Oral tablets

• Package Size: 60 tablets per bottle

Pharmacokinetics

Turinabol has an estimated half-life of 16 hours, allowing for once or twice daily dosing in research settings. It provides moderate anabolic activity with low androgenic impact and does not convert to estrogen, reducing risk of estrogen-related side effects in experimental applications.

Usage Recommendations

• Typical Research Dosage (historical reference): 20–50 mg per day

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human medical use or consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with existing medical conditions. Always follow local regulations and scientific handling standards.